TP53 and colorectal carcinoma: To evaluate p53-independent efficacy of PRIMA-1Met, we selected a series of CRC cell lines representative of different TP53 heterogeneity, including TP53wt (HCT116wt and LOVO), TP53mut (SW480, DLD-1 and HT29) and TP53neg (HCT116neg).